Ospedale San Salvatore

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Colorectal cancer1 trial
• Familial hypercholesterolaemia1 trial

Phase

• Phase 31 trial

Status

• Active, not recruiting2 trials

Lead sponsor

• Azienda USL Reggio Emilia - IRCCS1 trial
• Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company1 trial

Running trials

• Active, not recruiting

  Study in mCRC Patients RAS/BRAF wt Tissue and RAS Mutated LIquid BIopsy to Compare FOLFIRI Plus CetuxiMAb or BevacizumaB

  NCT04776655· Phase 3· Azienda USL Reggio Emilia - IRCCS· Source

• Active, not recruiting

  Treatment With Bempedoic Acid and/or Its Fixed-dose Combination With Ezetimibe in Primary Hypercholesterolemia or Mixed Dyslipidemia

  NCT04579367· Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company· Source